NCT00130143View on ClinicalTrials.gov

Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

September 30, 2004

Conditions
Head and Neck CancerLung Cancer
Interventions
DRUG

Ethyol (Amifostine)

Trial Locations (1)

18301

The Dale & Frances Hughes Cancer Center, East Stroudsburg

Sponsors

Collaborators (1)

MedImmune LLC
All Listed Sponsors
collaborator

MedImmune LLC

INDUSTRY

lead

The Dale & Frances Hughes Cancer Center

OTHER